A.K. RAMAZANOVA^{1, 2}, D.I. ABDULGANIEVA², I.G. MUSTAFIN², A.K. ODINTSOVA¹, B.R. RAMAZANOV²

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation 420012

²Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan, 138 Orenburgskiy Trakt, Kazan, Russian Federation 420064

Ramazanova A.Kh. — physician of the Department of Gastroenterology, postgraduate student of the Department of Biochemistry, tel. +7-927-404-74-40,

e-mail: alsuramazan@mail.ru^1,2

Abdulganieva D.I. — D. Med. Sc., Head of the Department of Hospital Therapy, tel. +7-987-296-27-68, e-mail: diana_s@mail.ru²

Mustafin I.G. — D. Med. Sc., Professor, Head of the Department of Biochemistry, tel. (843) 236-68-82, e-mail: ilshat64@mail.ru²

Odintsova A.K. — Cand. Med. Sc., Head of the Department of Gastroenterology, tel. +7-987-290-53-44, e-mail: odincovaa@yandex.ru¹

Ramazanov B.R. — postgraduate student of the Department of Pathophysiology, tel. +7-927-244-29-66, e-mail: bulatramazan@mail.ru²

The article presents the study of changes in the haemostatic system in patients with exacerbation of inflammatory bowel disease. The spatial dynamics of blood plasma coagulation in patients with Crohn’s disease and ulcerative colitis was studied. The results showed that patients with Crohn’s disease tend to have more pronounced hypercoagulable disorders of haemostasis.

Key words: inflammatory bowel disease, thromboembolic complications, spatial dynamics of blood plasma coagulation, hypercoagulability.

REFERENCES

1. Freeman H.J. Venous thromboembolism with inflammatory bowel disease. World J. Gastroenterol., 2008, vol. 14, no. 7, pp. 991-993.

2. Scaldaferri F., Lancellotti S., Pizzoferrato M., De Cristofaro R. Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. World J. Gastroenterol, 2011, vol. 17, pp. 594-608.

3. Owczarek D., Cibor D., Głowacki M. et al. Inflammatory bowel disease: epidemiolo-gy, pathology and risk factors for hypercoagulability. World J. Gastroenterol., 2014, vol. 20, no. 1, pp. 33-63.

4. Jackson L.M., O’Gorman P.J., O’Connell J. et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. Q.J.M., 1997, vol. 9, pp. 183-188.

5. Ivashkin V.T., Shelygin Yu.A., Abdulganieva D.I. et al. Draft clinical guidelines for the diagnosis and treatment of adult patients with Crohn’s disease. Koloproktologiya, 2013, no. 3, pp. 3-34 (in Russ.).

6. Lewis J.D., Chuai S., Nessel L. et al. Use of the Non-invasive Components of the Mayo Score to Assess Clinical Response in Ulcerative Colitis. Inflamm. Bowel Dis., 2008, vol. 14, no. 12, pp. 1660-1666.

7. Best W.R., Becktel J.M., Singleton J.W. Rederived values of the eight coefficients of the Crohn’s disease activity index (CDAI). Gastroenterology, 1979, vol. 77, pp. 843-846.